News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
51 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8500)
Month
January (3339)
February (3294)
March (4068)
April (3457)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (2)
2 (5)
3 (51)
4 (11)
5 (136)
6 (140)
7 (50)
9 (2)
10 (140)
11 (193)
12 (119)
13 (155)
14 (53)
15 (2)
16 (5)
17 (153)
18 (162)
19 (149)
20 (175)
21 (74)
23 (5)
24 (163)
25 (169)
26 (152)
27 (186)
28 (69)
29 (4)
30 (4)
31 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
Zealand Pharma A/S announced results from Part 1 of a multiple ascending dose trial for ZP8396, the company’s long-acting amylin analog with potential for the management of overweight and obesity.
July 3, 2023
·
6 min read
Business
Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth
Bionomics Limited announced key leadership updates to drive its ongoing transformation to a U.S.-focused company, streamline its allocation of capital, and support its next stage of strategic growth.
July 3, 2023
·
5 min read
BioMidwest
IDACIO® (adalimumab-aacf) Now Available in the United States
Fresenius Kabi announced today the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all eligible indications of the reference product, Humira® (adalimumab).
July 3, 2023
·
12 min read
Deals
Xtant Medical Announces $15 Million Private Placement
Xtant Medical Holdings, Inc. today announced it has entered into a securities purchase agreement with accredited investors to sell shares of its common stock in a private placement.
July 3, 2023
·
5 min read
Drug Development
CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China Based on Interim Analysis of Independent Data Monitoring Committee
CANbridge Pharmaceuticals, Inc. announced that, based on the interim analysis recommendation of the independent data monitoring committee, it plans to continue the ongoing Phase 2 study of CAN008 in patients with newly diagnosed glioblastoma multiforme (GBM) in China to completion.
July 3, 2023
·
4 min read
Business
AtriCure to Announce Second Quarter 2023 Financial Results
AtriCure, Inc. today announced that it will release second quarter 2023 financial results on Tuesday, July 25, 2023.
July 3, 2023
·
1 min read
Genetown
Sarepta Therapeutics to Present at Cowen’s 2nd Annual RNA Therapeutics Summit
Sarepta Therapeutics, Inc. today announced that senior management will participate in a fireside chat at Cowen’s 2nd Annual RNA Therapeutics Summit on Monday, July 10, 2023 at 11:00 a.m. E.T.
July 3, 2023
·
1 min read
Business
Align Technology to Announce Second Quarter 2023 Results on July 26, 2023
Align Technology, Inc. today announced that it will report second quarter 2023 financial results on Wednesday, July 26, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT).
July 3, 2023
·
2 min read
Deals
Soaak Technologies Acquires RenuYou Clinics, Expanding its Innovative Solutions for Mental Strength and Physical Well-being
Soaak Technologies has announced its acquisition of RenuYou Clinics, a prestigious fifteen-year-old Board Certified clinic, specializing in a wide range of personalized therapies, including brain mapping and neurofeedback.
July 3, 2023
·
2 min read
Lunit’s AI-Powered Lung Cancer Screening Solution Significantly Affects Radiologists’ Diagnostic Determination - Published in Radiology
Findings from a recent study demonstrate that medical AI solutions with only high diagnostic accuracy can significantly improve the reading performance of radiologists.
July 3, 2023
·
4 min read
Previous
4 of 6
Next